RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 10:11 AM
Followers: 439
Posts Today: 4
Views Today: 72054

CYDY Stock Quote & Tools

$0.2094 ▲ +0.0040 (+1.94%) As of Oct 16, 10:00 AM EDT
Last0.2094
$ Chg0.0040
Open0.2050
High0.2190
Beta1.4964
Year High0.397
Market Cap307.64M
P/B Ratio-2.68
EPS-0.04
Avg Vol (30d)1.57M
Volume629.8K
% Chg+1.94%
Prev Close0.2054
Low0.2050
VWAP0.21167
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. CDiddy

    I actually think it's good that they left that garbage out of the PR. Makes me think it may

    (6)
  2. reallypeople?

    Just means phase 3 will be filed . No biggy all expected .

    (1)
  3. Bw

    I cant remember the source but was under the impression that they were being proactive in enrolling

  4. Number1Stocker

    Flash back to our last and only Monday CC post#82777 Just to see then to now

    (1)
  5. ohm20

    We never get trial results early. Nader said late June. This is mid June. Would they be

    (3)
  6. Evil Rabbit

    He posted another link in the next post.

  7. sean007

    suddenly unavailable?...anyone ??

  8. PennySlayer

    Think about it. We never get trial results early. Nader said late June. This is mid June. Would

    (7)
  9. PennySlayer

    See my follow up post.

  10. CTMedic

    Pennyslayer, This will not be the only video of great results from LH trial. Others will be

    (5)
  11. TechGuru

    And buy some more .... Which is what I am doing in spite of my wife's disapproval :) Science

    (11)
  12. Flash08

    Shorts better be worried

    (3)
  13. PennySlayer

    https://www.reddit.com/r/CYDY/comments/o1guxa/elis_final_visit_with_dr_gaylis/?utm_medium=android_a

    (10)
  14. PennySlayer

    Shorts......please enjoy this short video. https://youtu.be/QvACNhv-ALK

  15. misiu143

    Sean , you are right , Alz is a terrible disease , but with COVID some dying within a week or two,

    (12)
  16. MarcS

    Did Nader finally pull a don't blink moment? We will see between now and Monday afternoon. This PR

    (3)
  17. PTM1

    The emphasis appears to be unblinded LH results. Please explain your hope for pre-enrollment data

  18. Bw

    Hoping for solid results and good numbers on pre enrollment into a phase 3 .....

    (2)
  19. sean007

    Alzheimer's is an ugly, debilitating disease that robs the family of a person far too long before

    (3)
  20. TonyCorvette

    $CYDY ICYMI

    (2)
  21. sean007

    I think there will be much tea reading done until after CC.

    (1)
  22. nothingspecial

    Checked out a few of the most liked posts.(15 likes per 250 views). I have never had such a great

    (5)
  23. sean007

    The Friday cover should be interesting...I think a little rise in SP will be in

    (3)
  24. Figgs

    In context of this new FDA discussion I again read the FDA "hit" letter. It's abusive and

    (4)
  25. hoops

    Sorry, didn't check the board. Still, very interested to hear anything regarding long haulers.

    (1)
  26. hoops

    https://www.cytodyn.com/newsroom/press-releases/detail/539/cytodyn-to-hold-webcast-on-june-21-to-di

    (1)
  27. Riztheinvestor

    No your right. I liked the clip they had up tho.

  28. Riztheinvestor

    Its absolutely crazy. I hope people continue to give push back.

    (2)
  29. AngryMan

    Some mentioned advocacy groups are funded by BP. Don't know how true. What a corrupt

    (5)
  30. misiu143

    Oh yeh , BTW it is 56,000 .00 a year..you are right , for something not working and something

    (12)
  31. dfwl28

    I wonder if insurance companies will cover this Alz drug in the face of the outspoken objections of

    (4)
  32. Dvb

    See this link for a table that lists all official FDA Guidance Documents and other regulatory

    (1)
  33. nmbr1stckpckr

    lol. CNN SUCKS! so I wouldn't use them as a claim of your open-mindedness. I heard about this

    (3)
  34. MarcS

    and regulatory advancements. This language seems more positive than usual.

    (2)
  35. Kevin0461

    I like how there is no fluff in the PR thats gotta mean that there is some really big

    (4)
  36. nmbr1stckpckr

    Wow, I don't want to commit to my mind that this is happening. Its actually happening in the time

    (3)
  37. Ganesha

    And, oh by the way, at a cost of $56,000 per patient per year!!! For a drug that doesn't work and

    (11)
  38. Riztheinvestor

    Good point ! Lets hope.

  39. Evil Rabbit

    Market wont dig the lack of emotive language in PR. Typically there would be a Nader quote

    (5)
  40. Riztheinvestor

    June 21st webcast ! Long Haulers :)

    (3)
  41. zagnut

    CytoDyn to Hold Webcast on June 21 to Discuss Unblinded Data from COVID-19 Long-Haulers Trial and

    (4)
  42. dfwl28

    "And 9 years later we will talk about it.." Read More:

    (6)
  43. misiu143

    Riztheinveator , This decision , if no other decision from the FDA before , put me completely in a

    (11)
  44. HCIT

    Who knows Sean007. CYDY has been quiet lately and that could be a good thing. I think, IMO of

    (1)
  45. Riztheinvestor

    Just in case anyone thinks the FDA was ever looking out for us.... Look at this thats been

    (6)
  46. Number1Stocker

    Remember if not all but MORE than most LONGS in PreCOVID, we a joined for Cancer or HIV. There was

    (5)
  47. sean007

    THANKS for the strategy Evil...your reward is in Heaven.

    (1)
  48. sean007

    "intend"...portend is more likely...underhanded mischief-makers "intend to have discussions"...I

    (1)
  49. smurph

    I hope they use LL on delta in Brazil, India... The CDC has classified the delta coronavirus

    (6)
  50. sean007

    "Trust Us"...their opening gambit on the (chess)Board was conniving...with malicious intent...ZERO

    (3)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Havila Shipping ASA Announces Resounding Bond Placement Success

Updated Category News Views 95

Havila Shipping ASA Secures NOK 525 Million Through Bond Issue Havila Shipping ASA is excited to share the successful completion of a significant financial milestone with the issuance of a senior secured bond totaling NOK 525 million. This two-year bond, initiated by Havila Finans AS—a fully owned subsidiary of Havila Holding AS, which holds a 50.96% stake in Havila...

Continue Reading
P0 Security Recognized in Fortune Cyber 60 for Excellence

Updated Category News Views 98

P0 Security Achieves Recognition Again P0 Security, a leading provider of unified identity governance and privileged access management (IGA and PAM) solutions for the cloud, has proudly made it onto the Fortune Cyber 60 list for the second consecutive year. This recognition reflects the company's significant contribution to enhancing cloud security among enterprises of...

Continue Reading
Heidrick & Struggles: Leading the Future at Baird Conference

Updated Category News Views 182

Heidrick & Struggles to Participate in Baird's Global Conference Heidrick & Struggles International, Inc. (NASDAQ: HSII) has announced that its Chief Executive Officer, Tom Monahan, along with Chief Financial Officer, Nirupam Sinha, will take part in a significant dialogue at the renowned Baird Global Consumer, Technology & Services Conference. Attendees can look forward...

Continue Reading
RainFocus Unveils Key Trends for 2026 B2B Marketing Landscape

Updated Category News Views 231

RainFocus Unveils Key Trends for 2026 B2B Marketing Landscape RainFocus is known for providing innovative event marketing solutions, and its recent forecast for 2026 reveals exciting insights that are set to reshape the B2B marketing landscape. These predictions reflect an evolution, showcasing the increasing emphasis on experiential engagement and artificial...

Continue Reading
Avista Corp. Announces Dividend Increase for Shareholders

Updated Category News Views 123

Avista Corp. Increases Common Stock Dividend Avista Corp. (NYSE: AVA) has recently made a notable announcement regarding its common stock dividend, declaring a quarterly dividend of $0.49 per share. This new dividend reflects an increase of $0.015 per share, translating to an annualized dividend of $1.96. Shareholders can expect the payment on a set date, specifically...

Continue Reading